MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today that it...
Ehave's Covid Passport provides small businesses a tool to verify Covid-19 vaccination, and a suite of products to improve both the mental and overall health of individuals.
CARLY CASSELLA 13 AUGUST 2021
Oral ketamine, known both as an anesthetic and a recreational drug, has recently emerged as a highly promising, rapid treatment for severe depression.
Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low.Launching Clinical Trial With Brain Scientific to Monitor Ketamine Efficacy.Launching Clinical Trial With Mycotopia Therapies and PsyBioMed.Launching...
Therapy Treatment Performed by Ehave’s (EHVVF) Chief Medical Office Dr. Jeffrey Kamlet Received Rave Reviews and Offers the Potential to Save Lives.
MIAMI BEACH, Fla. (CBS12) — Last month,...
